Liu M - Search Results

1

[Study on diagnostic accuracy of ultrasound-guided core needle breast biopsy].

Liu M, Chen W, Li XR, Li JL, Wang JD, Zhang YJ, Zheng YQ, Wei LX. Liu M, et al. Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):739-42. Zhonghua Bing Li Xue Za Zhi. 2010. PMID: 21215163 Chinese.

2

[A clinicopathological study of fifteen epithelioid angiosarcoma].

Liu M, Ba E, Zhao P, Li X. Liu M, et al. Zhonghua Bing Li Xue Za Zhi. 2002 Oct;31(5):407-10. Zhonghua Bing Li Xue Za Zhi. 2002. PMID: 12485481 Chinese.

3

[Pathologic diagnoses of core needle biopsies of the mediastinum].

Liu M, Hou N, Song X, Yu DJ, Zhao P, Li XH. Liu M, et al. Zhonghua Bing Li Xue Za Zhi. 2004 Apr;33(2):135-9. Zhonghua Bing Li Xue Za Zhi. 2004. PMID: 15132850 Chinese.

4

[Expression of ER, PR and cyclin D1 in breast infiltrating ductal carcinoma and their clinicopathological significance].

Wang ZB, Zhao P, Liu M, Li XH. Wang ZB, et al. Among authors: liu m. Zhonghua Yi Xue Za Zhi. 2005 Mar 2;85(8):514-7. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15949328 Chinese.

5

[Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof].

Wang ZB, Zhao P, Liu M, Li XH. Wang ZB, et al. Among authors: liu m. Zhonghua Yi Xue Za Zhi. 2006 Aug 22;86(31):2171-6. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17064501 Chinese.

6

Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.

Li XR, Liu M, Zhang YJ, Wang JD, Zheng YQ, Li J, Ma B, Song X. Li XR, et al. Among authors: liu m. Med Oncol. 2011 Dec;28 Suppl 1:S31-8. doi: 10.1007/s12032-010-9676-z. Epub 2010 Sep 16. Med Oncol. 2011. PMID: 20844986

7

ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.

Li XR, Liu M, Zhang YJ, Wang JD, Zheng YQ, Li J, Ma B, Song X. Li XR, et al. Among authors: liu m. Med Oncol. 2011 Dec;28 Suppl 1:S48-54. doi: 10.1007/s12032-010-9693-y. Epub 2010 Sep 25. Med Oncol. 2011. PMID: 20872186

8

CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients.

Li XR, Liu M, Zhang YJ, Wang JD, Zheng YQ, Li J, Ma B, Song X. Li XR, et al. Among authors: liu m. Med Oncol. 2011 Dec;28 Suppl 1:S129-34. doi: 10.1007/s12032-010-9742-6. Epub 2010 Nov 16. Med Oncol. 2011. PMID: 21080107

9

DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.

Li XR, Cheng LQ, Liu M, Zhang YJ, Wang JD, Zhang AL, Song X, Li J, Zheng YQ, Liu L. Li XR, et al. Among authors: liu m, liu l. Med Oncol. 2012 Jun;29(2):425-31. doi: 10.1007/s12032-011-9842-y. Epub 2011 Feb 1. Med Oncol. 2012. PMID: 21286861

10

Intraoperative radiotherapy in patients with breast cancer treated by breast-conserving therapy.

Zhang YJ, Liu L, Ma L, Yu W, Liu M, Cheng LQ, Li J, Zheng YQ, Wang JD, Kong QL, Li XR. Zhang YJ, et al. Among authors: liu m, liu l. Tumori. 2012 Nov;98(6):736-42. doi: 10.1177/030089161209800610. Tumori. 2012. PMID: 23389360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,161 results

Search Page

Filters